HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Analysis of skeletal-related events in breast cancer and response to therapy.

Abstract
The skeleton is a common site for the spread of metastatic cancer and skeletal complications are a cause of significant morbidity and mortality. Treatment of skeletal morbidity is therefore an essential component of therapy for cancer patients with bone metastases. Bisphosphonates are currently the treatment of choice for skeletal complications. In a patient diagnosed with bone metastases, skeletal morbidity is evaluated by a number of endpoints known as skeletal related events. These include bone pain, requirement for radiation or surgery to bone, pathologic and radiologic fractures, hypercalcemia, and progression of bone metastases. The efficacy of bisphosphonate treatment is evaluated by their effect on the number and frequency of skeletal-related events. In addition, surrogate markers of bone resorption such as collagen telopeptides or quality of life measurements can be used to monitor therapy, though these do not necessarily reflect skeletal morbidity. Intravenous pamidronate is currently the standard treatment for patients with bone metastases, and is effective in reducing the frequency of a variety of skeletal-related events. The more potent bisphosphonates ibandronate and zoledronate are now being evaluated in this setting. These agents may offer advantages over pamidronate in terms of convenience of administration. Clinical trials underway will determine whether they are equivalent or even superior to pamidronate in reducing skeletal-related events.
AuthorsP LoRusso
JournalSeminars in oncology (Semin Oncol) Vol. 28 Issue 4 Suppl 11 Pg. 22-7 (Aug 2001) ISSN: 0093-7754 [Print] United States
PMID11544572 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright 2001 by W.B. Saunders Company.
Chemical References
  • Diphosphonates
Topics
  • Bone Neoplasms (physiopathology, secondary, therapy)
  • Breast Neoplasms (pathology)
  • Diphosphonates (therapeutic use)
  • Fractures, Spontaneous
  • Humans
  • Hypercalcemia
  • Morbidity
  • Spinal Cord Compression

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: